Kontos, D. (2024). The promise of AI in personalized breast cancer screening: are we there yet? Nature Reviews Clinical Oncology, 21(6), 403–404. https://doi.org/10.1038/s41571-024-00877-z

Shah, M. A., Altorki, N., Patel, P., Harrison, S., Bass, A., & Abrams, J. A. (2023). Improving outcomes in patients with oesophageal cancer. Nature Reviews Clinical Oncology, 20(6), 390–407. https://doi.org/10.1038/s41571-023-00757-y

Mair, M. J., Bartsch, R., Le Rhun, E., Berghoff, A. S., Brastianos, P. K., Cortes, J., Gan, H. K., Lin, N. U., Lassman, A. B., Wen, P. Y., Weller, M., van den Bent, M., & Preusser, M. (2023). Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours. Nature Reviews Clinical Oncology, 20(6), 372–389. https://doi.org/10.1038/s41571-023-00756-z

Carvajal, R. D., Sacco, J. J., Jager, M. J., Eschelman, D. J., Olofsson Bagge, R., Harbour, J. W., Chieng, N. D., Patel, S. P., Joshua, A. M., & Piperno-Neumann, S. (2023). Advances in the clinical management of uveal melanoma. Nature Reviews Clinical Oncology, 20(2), 99–115. https://doi.org/10.1038/s41571-022-00714-1

Vasan, N., & Cantley, L. C. (2022). At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy. Nature Reviews Clinical Oncology, 19(7), 471–485. https://doi.org/10.1038/s41571-022-00633-1